Clinical Trials Academy: Protocol Execution (CTA2)
Course covering trial activities necessary to conduct a study with consistency and scientific rigor
Who?
Qualified applicants will have completed CTA 1 or have equivalent training or practical experience in designing or conducting investigator-initiated clinical trials. Ideally, they will have a protocol in hand ready for the launch of an investigator-initiated clinical trial.
When?
Application and course information for next year’s cohort will be shared early summer on the MICHR news page.
How much?
Free
What is this offering?
Clinical Trials Academy: Protocol Execution (CTA2) is designed to help investigators successfully and efficiently execute a well-designed protocol. The course covers trial activities necessary to conduct a study with consistency and scientific rigor, from study start-up, through study conduct, to close-out. Participants will learn to apply the concepts covered in lectures through hands-on exercises where an instructor will coach investigators and their clinical research coordinators on developing essential trial tools, such as building a database, writing a manual of procedures, registering a trial in clinicaltrials.gov, preparing a trial budget, monitoring trial progress, and executing closeout activities.
How this advances translational science
Implementing operations that facilitate and support the quality and impact of research
Translational Science Categories: